A damp building can worsen respiratory health, but no single blood test proves that a particular indoor mold caused your symptoms. The useful test depends on whether the clinical question is allergy, invasive fungal infection, or another illness entirely.
- Mold-specific IgE can show allergic sensitization to a named mold, but it cannot prove that your home or workplace is the source.
- Total IgE above 100 IU/mL is nonspecific; eczema, pollen allergy, parasites, and smoking can also raise it.
- Eosinophils above 500 cells/µL support an allergic or parasitic pattern but do not diagnose mold illness.
- Galactomannan and beta-D-glucan are infection tests for selected high-risk patients, not screening tests after ordinary household exposure.
- Mycotoxin blood test accuracy has not been established for diagnosing illness from indoor mold exposure.
- CBC, CRP, liver, and kidney panels can assess alternative explanations or complications, but normal values do not rule out respiratory allergy.
- Urgent review is appropriate for breathlessness at rest, oxygen saturation below 92%, coughing blood, persistent fever above 38.0°C, or immunosuppression.
- Environmental action means fixing dampness and visible growth; medical testing should follow symptoms and risk factors, not a home test alone.
What a blood test can actually tell you after mold exposure
Mold exposure blood tests can identify mold allergy in some people and can support investigation of invasive fungal infection in high-risk patients; they cannot diagnose a broad, undefined condition called “mold toxicity.” As of September 18, 2026, no validated blood marker can link a nonspecific symptom cluster to a particular damp room, wall, or species of indoor mold.
The practical question is not “Which mold test do I need?” but “What illness are we trying to confirm?” A mold allergy blood test measures IgE antibodies to allergen extracts; an infection workup looks for fungal disease in a patient with compatible symptoms and major risk factors; neither test measures the amount of mold a person inhaled.
In my 15 years of clinical practice, I have seen people spend hundreds on broad panels when a careful history found asthma, allergic rhinitis, reflux, sleep loss, or an unrelated viral illness. Dr. Thomas Klein's first step is usually to map the timing: symptoms that improve over 1 to 2 weeks away from a building deserve a different discussion from symptoms that continue unchanged on holiday.
Kantesti is an AI blood test analyzer that reads a CBC, differential, CRP, liver markers, and kidney markers as clinical context rather than presenting them as proof of indoor mold disease. That distinction protects patients from treating a laboratory flag instead of the condition actually causing it; see our biomarker reference guide.
When mold-specific IgE testing is useful
Mold-specific IgE testing is useful when sneezing, itchy eyes, wheeze, cough, or nasal blockage repeatedly follow exposure to damp spaces, outdoor spores, or compost. A positive result establishes sensitization, not the severity of disease or the location of exposure.
Laboratories commonly report specific IgE from 0.10 kUA/L upward, although a result of 0.35 kUA/L or higher has historically been called positive. These analytic cutoffs are not symptom thresholds: a 2.0 kUA/L result may be clinically irrelevant without a matching exposure history, while a lower result can matter in a patient with reproducible wheeze.
Mold extracts vary considerably between laboratories because they contain mixtures of proteins, and cross-reactivity between Alternaria, Cladosporium, Aspergillus, Penicillium, and outdoor fungi is common. The molecular allergy testing guide explains why component testing can sometimes clarify a confusing extract-based result, although components are not available for every mold.
A negative serum IgE result does not exclude non-allergic irritation from poor air quality, and it does not exclude asthma. The World Health Organization's 2009 dampness and mould guidance links damp indoor environments with respiratory symptoms and asthma, but it does not endorse serum IgE as a building-exposure meter.
Blood IgE versus skin-prick testing for suspected mold allergy
Skin-prick testing and serum mold-specific IgE usually answer the same question—whether IgE sensitization exists—but neither test can prove causation from a building. Skin testing gives an answer in about 15 minutes, while blood testing is useful when antihistamines cannot be stopped or skin testing is impractical.
A skin-prick wheal is often considered positive when it is 3 mm larger than the negative control, but the interpretation depends on a valid histamine control and trained technique. Antihistamines can suppress a skin result for several days, whereas serum specific IgE is not altered by antihistamines.
Some patients assume blood testing is inherently more accurate because it feels more technical. That is not quite right: allergy specialists choose the method that best fits the patient, the availability of standardized extracts, and the clinical history; our qualitative versus quantitative test guide explains why a numeric result can still have limited diagnostic meaning.
If asthma symptoms began after a water-damage event, spirometry with bronchodilator testing often adds more actionable information than ordering 20 fungal IgE tests. A fall in FEV1 with reversibility after bronchodilator can establish airway physiology that an antibody result cannot.
Total IgE and eosinophils: supportive clues, not mold tests
Total IgE and eosinophils can support an allergic pattern, but neither marker identifies mold as the trigger. Total IgE commonly has an adult laboratory reference interval near 0 to 100 IU/mL, while an absolute eosinophil count above 500 cells/µL is usually called eosinophilia.
An eosinophil percentage is less useful than the absolute eosinophil count, because a low or high total white-cell count can distort the percentage. Counts of 500 to 1,500 cells/µL are mild eosinophilia; counts above 1,500 cells/µL on repeat testing deserve a broader evaluation for medication reactions, parasites, lung disease, autoimmune disease, and hematologic causes.
I recently reviewed a patient with total IgE of 680 IU/mL and an eosinophil count of 780 cells/µL after moving into a damp flat. She did have allergic rhinitis, but stool testing and travel history ultimately identified a parasitic exposure—an easy miss if we had labelled the numbers “mold toxicity” on day one. Read more about high eosinophil patterns.
Very high total IgE—often above 1,000 IU/mL—can appear in allergic bronchopulmonary aspergillosis (ABPA), severe eczema, parasitic infection, and other conditions. It is a prompt for targeted clinical workup, not a result to detox.
The uncommon situation: allergic bronchopulmonary aspergillosis
ABPA is an immune lung disorder most often considered in people with asthma or cystic fibrosis who have recurrent wheeze, mucus plugging, fleeting chest-imaging changes, and Aspergillus sensitization. It is not diagnosed by a home mold test or by total IgE alone.
The 2024 ISHAM-ABPA working group recommends a total IgE of at least 500 IU/mL as one essential threshold in a compatible clinical setting, together with fungal sensitization and additional features such as Aspergillus-specific IgG, eosinophils of at least 500 cells/µL, or characteristic imaging. Earlier criteria used 1,000 IU/mL, so old internet advice may be too restrictive.
A chest CT can show central bronchiectasis or mucus impaction, while a simple CBC may be normal between flares. The 2016 IDSA aspergillosis guideline also separates allergic disease from invasive infection; these are biologically and clinically different conditions (Patterson et al., 2016).
ABPA treatment decisions may involve oral corticosteroids, antifungal therapy, or biologic asthma treatment and need specialist oversight because liver enzymes and drug interactions matter. If monitoring is required, review a liver panel result with the prescribing clinician rather than changing medication based on one ALT value.
Why IgE trends matter after diagnosis
After ABPA treatment begins, clinicians often use a fall in total IgE of roughly 25% or more alongside symptoms and imaging as one marker of response. The absolute value may remain high for months, so a single “abnormal” result is much less informative than a measured trend.
When blood tests are used for invasive fungal infection
Fungal infection blood tests are reserved for people with substantial risk—such as prolonged neutropenia, stem-cell transplant, high-dose immunosuppression, or critical illness—not for routine evaluation of household mold exposure. Fever, lung symptoms, and the immune context determine whether testing is appropriate.
Serum galactomannan can support a diagnosis of invasive aspergillosis in selected high-risk patients, particularly those with hematologic malignancy or transplant exposure. A typical serum positivity index is 0.5 or greater, but false positives and false negatives occur, and performance differs substantially after mold-active antifungal medication.
Beta-D-glucan is a cell-wall marker shared by many fungi; many laboratories regard 80 pg/mL or higher as positive, but it does not identify a fungal species and may be elevated after some intravenous products, dialysis filters, severe bacterial infection, or gauze exposure. It is not a test for “mold in the body.”
The IDSA guideline recommends integrating CT imaging, respiratory samples, cultures, antigen tests, and host risk rather than relying on one serum assay (Patterson et al., 2016). A low neutrophil count needs separate attention; our neutrophil range guide gives the usual ANC cutoffs.
Why mycotoxin blood and urine tests cannot diagnose indoor mold illness
Mycotoxin blood test accuracy has not been validated for diagnosing illness from ordinary indoor mold exposure. Detecting a compound in blood or urine, when an assay detects it at all, does not establish the source, dose, timing, tissue effect, or cause of symptoms.
Mycotoxins are chemicals made by some fungi under particular growth and food-storage conditions, and dietary exposure can occur through grains, coffee, dried fruit, nuts, and spices. A urine finding therefore cannot distinguish a meal eaten 24 hours earlier from a building-related exposure without validated reference populations and exposure models.
The Centers for Disease Control and Prevention warned in 2015 that unvalidated urine mycotoxin tests should not be used to diagnose illness related to water-damaged buildings. The central problem is analytical versus clinical validity: a laboratory can measure a molecule precisely and still lack evidence that the result diagnoses a disease.
I am cautious when a patient is offered binders, antifungals, or repeated testing based only on a mycotoxin panel. Antifungal drugs can cause hepatotoxicity and QT-related interactions; unexplained changes in ALT, AST, or bilirubin need proper interpretation, as outlined in our ALT follow-up guide.
What routine blood work can contribute
A CBC, CRP, metabolic panel, and selected allergy markers can identify anemia, infection patterns, organ dysfunction, or eosinophilia, but they do not confirm mold exposure. Their main value is preventing a premature explanation when symptoms have another treatable cause.
A CRP below 5 mg/L is common in well adults and does not rule out allergic rhinitis or asthma; CRP often rises with bacterial infection, autoimmune activity, obesity, and many other conditions. An isolated mildly raised CRP is a poor proxy for indoor air exposure, especially after a recent cold or hard exercise.
Kantesti is an AI blood test interpretation platform that compares results with the laboratory's own reference intervals and related markers, because a CRP of 12 mg/L with neutrophilia suggests a different next step from CRP 12 mg/L with normal cells and severe seasonal nasal symptoms. For a useful starting framework, see our baseline testing checklist.
Kidney and liver tests are particularly useful before a clinician prescribes systemic antifungals or prolonged steroids. Creatinine, eGFR, ALT, AST, alkaline phosphatase, and bilirubin assess treatment safety; they are not fungal exposure biomarkers.
Symptoms that fit mold allergy—and symptoms that need another workup
Mold-related allergy most often causes nasal congestion, sneezing, itchy or watery eyes, cough, wheeze, and asthma flares that track with exposure. Brain fog, fatigue, nausea, and headache are real symptoms but are too nonspecific to diagnose a mold-related condition from blood results.
Symptoms beginning within minutes to hours of entering a damp building and easing away from it raise the probability of an airway trigger. Keep a 14-day diary of location, time indoors, peak-flow readings if you have asthma, sleep, fever, medications, and visible dampness; this creates evidence a clinician can actually use.
Persistent fatigue with normal oxygen levels and no cough may justify checking sleep, mood, thyroid function, iron status, B12, glucose, and medication effects rather than assuming fungal illness. Our guide to blood tests for low mood covers several medical mimics that can coexist with environmental stress.
A 52-year-old runner with an AST of 89 IU/L after a weekend race does not suddenly have mold-related liver disease—muscle exertion is a frequent explanation, particularly if CK is elevated. Clinical timing beats a single dramatic interpretation.
How to investigate the building without medical overtesting
Visible mold, musty odor, recurrent condensation, water staining, and measured dampness justify fixing the moisture source; routine air sampling rarely changes the immediate health advice. The building intervention is to stop water entry, dry materials, and remove contaminated porous materials when necessary.
Indoor spore counts vary by weather, ventilation, season, sampling location, and the outdoor background on the same day. A “normal” air sample can miss hidden moisture damage, while a high count does not show that a particular resident is ill from it.
The WHO guidance emphasizes prevention and remediation of persistent dampness rather than acceptable indoor mold-count targets. For a person with asthma, moving temporarily away from obvious dampness while the problem is repaired can be a sensible clinical experiment—provided housing safety and access are addressed.
Photograph visible changes, document dates of leaks, and keep copies of repair reports. Those details are more useful at an allergy or respiratory appointment than a commercial antibody panel; our health history tracker can help organize laboratory and symptom timelines.
Common false positives and misleading results
The most misleading mold-related result is a positive antibody test without matching symptoms, because sensitization is common and may reflect outdoor exposure rather than illness. Cross-reactive allergens, broad fungal extracts, and testing when pre-test probability is low all increase false-positive harm.
A result can be analytically correct yet clinically false-positive for the question being asked. If 100 people without convincing allergy symptoms are tested against many mold extracts, several will have detectable IgE simply by chance or from harmless sensitization; this is why indiscriminate panels create anxiety.
Total IgE may rise after eczema flares, smoking, parasitic infection, and other allergic conditions. Likewise, a high IgE result does not rank one trigger above another and cannot tell whether remediation will improve symptoms.
Specimen handling also matters for infection tests. Hemolysis, delayed processing, recent immunoglobulin infusion, antibiotics, and antifungal treatment can change antigen-assay interpretation, so a specialist should know what you received in the previous 7 to 14 days.
A sensible testing plan based on risk
Most people with suspected indoor mold exposure need a focused history, physical examination, and allergy or asthma assessment—not extensive blood panels. Testing escalates when there is persistent lower-respiratory disease, objective fever, immune suppression, abnormal imaging, or recurrent infections.
For nasal and eye symptoms, consider targeted mold-specific IgE or skin-prick testing if the history suggests an allergen pattern. For wheeze or cough, spirometry, peak-flow variation, inhaler response, and chest examination are often the first high-yield tests; the shortness of breath test guide explains where blood work fits.
For fever above 38.0°C, weight loss, coughing blood, focal chest findings, or oxygen saturation below 92%, clinicians usually prioritize urgent examination and chest imaging over consumer toxin testing. Immunocompromised patients should contact their treating team promptly because their threshold for fungal investigation is lower.
Kantesti's neural network can help users prepare a concise trend summary from existing laboratory reports, but it cannot diagnose fungal infection or replace an examination. Our clinical validation standards explain the boundaries of AI-supported result interpretation.
Why “detox” and empirical antifungals can backfire
Antifungal medication is not a general treatment for nonspecific symptoms after indoor mold exposure, and so-called detox regimens have not shown that they remove indoor-mold-related illness. Treatment should match a diagnosed condition such as allergic rhinitis, asthma, ABPA, or proven fungal infection.
Azole antifungals can cause nausea, liver-enzyme elevation, drug interactions, and in some cases electrical rhythm concerns. A medication such as itraconazole has a role in selected fungal conditions, but prescribing it after an unvalidated urine test exposes patients to risk without a demonstrated benefit.
Cholestyramine and activated charcoal can interfere with absorption of prescription medicines, including thyroid replacement, anticoagulants, and some contraceptives. If someone develops dark urine, jaundice, severe abdominal pain, or fainting after a supplement or antifungal, urgent assessment is safer than adding another product.
Dr. Thomas Klein advises bringing every supplement container to the appointment, including powders and binders. The supplements and liver safety guide is a useful reminder that “natural” does not mean metabolically harmless.
How to read results without overcalling mold illness
A result becomes meaningful only when the test, symptom pattern, exposure timing, examination, and alternative diagnoses agree. A positive mold-specific IgE with springtime wheeze is more persuasive than the same result in a person with fatigue alone and no respiratory symptoms.
Ask four direct questions: What does this test measure? What conditions was it validated to diagnose? Does my symptom pattern fit? What result would change treatment? If the answer to the last question is “none,” the test is unlikely to be useful.
Kantesti is an AI-powered blood test analysis tool used across 127+ countries to organize laboratory context and highlight questions for a clinician; it does not convert an eosinophil count or mycotoxin claim into an exposure diagnosis. For practical quality checks before sharing a report, read our AI report accuracy checklist.
Repeated testing should have a purpose. For example, an allergist may trend total IgE after confirmed ABPA, while a primary-care clinician may repeat a CBC in 4 to 8 weeks after transient eosinophilia; a positive specific IgE usually does not need serial measurement.
Research context, clinical boundaries, and your next appointment
The evidence supports preventing and remediating damp indoor conditions, diagnosing allergy with validated IgE methods, and reserving fungal infection assays for high-risk clinical situations. It does not support diagnosing indoor mold illness from mycotoxin results alone.
Mendell and colleagues reviewed epidemiologic evidence linking dampness and mold with respiratory and allergic outcomes, while also noting the difficulty of assigning disease to a single measured agent (Mendell et al., 2011). That is exactly why a good appointment includes respiratory history, building chronology, and targeted testing rather than a one-size-fits-all panel.
For broader laboratory context, our serum protein research guide explains why albumin and globulin changes require differential diagnosis rather than environmental assumptions. Kantesti's clinicians and Medical Advisory Board advocate transparent limits: an interpretation should say what a result cannot establish.
Bring the original laboratory report, medication list, symptom diary, relevant photographs, and any imaging reports to your appointment. If you have severe breathlessness, chest pain, confusion, blue lips, or oxygen saturation below 92%, seek urgent care rather than waiting for additional blood testing.
Frequently Asked Questions
Is there a blood test that proves mold exposure?
No validated blood test proves that a person was exposed to mold in a particular building or that mold caused their symptoms. Mold-specific IgE measures allergic sensitization to a tested extract, usually reported in kUA/L, but cannot identify the source location. CBC changes, CRP, total IgE, and eosinophils are nonspecific. Invasive fungal markers such as galactomannan are used only when infection is clinically plausible in a high-risk patient.
What does a positive mold allergy blood test mean?
A positive mold allergy blood test means that serum contains IgE antibodies that recognize the tested mold extract. Many laboratories historically call specific IgE at or above 0.35 kUA/L positive, although detectable sensitization may begin around 0.10 kUA/L. The result supports allergy only when symptoms such as wheeze, sneezing, or itchy eyes match exposure timing. It does not prove that mold in your home, office, or school is the cause.
Are mycotoxin blood tests accurate?
Mycotoxin blood tests do not have established clinical accuracy for diagnosing illness from household or workplace mold exposure. A detected chemical cannot reliably identify its source, because food can contribute to mycotoxin exposure and reference ranges for building-related illness are not validated. The CDC has warned against using unvalidated urine mycotoxin tests to diagnose illness from water-damaged buildings. A result should not be used alone to justify antifungal drugs, binders, or a mold-toxicity diagnosis.
Can mold exposure raise eosinophils?
Mold allergy can contribute to raised eosinophils, but an absolute eosinophil count above 500 cells/µL has many possible causes. Asthma, eczema, medication reactions, parasitic infection, autoimmune disease, and certain blood disorders can all raise the count. Persistent eosinophils above 1,500 cells/µL usually warrant a broader clinical evaluation. The absolute count is more informative than the eosinophil percentage alone.
When should I ask about fungal infection tests?
Ask about fungal infection testing when you have compatible illness plus substantial risk, such as prolonged neutropenia, organ or stem-cell transplant, high-dose immune-suppressing treatment, or critical illness. Serum galactomannan is often considered positive at an index of 0.5 or greater, while beta-D-glucan commonly uses 80 pg/mL as a positive threshold. Neither test is appropriate as a routine screen after visible household mold. Fever above 38.0°C, worsening breathlessness, or coughing blood requires prompt medical assessment.
Should I get a CBC after finding mold in my home?
A CBC can be reasonable if symptoms or medical history suggest infection, anemia, eosinophilia, medication effects, or another illness, but it cannot confirm mold exposure. A normal CBC does not exclude allergic rhinitis or asthma, and an abnormal CBC does not identify mold as the cause. Clinicians usually select a CBC based on symptoms such as fever, recurrent infections, fatigue, or unexplained bruising. For respiratory symptoms, spirometry and allergy assessment may be more informative than broad blood testing.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). aPTT Normal Range: D-Dimer, Protein C Blood Clotting Guide. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Serum Proteins Guide: Globulins, Albumin & A/G Ratio Blood Test. Kantesti AI Medical Research.
📖 External Medical References
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.